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ABSTRACT A mechanism of how polyanions inﬂuence the channel formed by Staphylococcus aureus a-hemolysin is
described. We demonstrate that the probability of several types of polyanions to block the ion channel depends on the presence
of divalent cations and the polyanion molecular weight and concentration. For heparins, a 10-fold increase in molecular weight
decreases the half-maximal inhibitory concentration, IC50, nearly 10
4-fold. Dextran sulfates were less effective at blocking the
channel. The polyanions are signiﬁcantly more effective at reducing the conductance when added to the trans side of this
channel. Lastly, the effectiveness of heparins on the channel conductance correlated with their inﬂuence on the z-potential of
liposomes. A model that includes the binding of polyanions to the channel-membrane complex via Ca2þ-bridges and the asym-
metry of the channel structure describes the data adequately. Analysis of the single channel current noise of wild-type and site-
directed mutant versions of a-hemolysin channels suggests that a single polyanion enters the pore due to electrostatic forces and
physically blocks the ion conduction path. The results might be of interest for pharmacology, biomedicine, and research aiming to
design mesoscopic pore blockers.doi: 10.1016/j.bpj.2009.09.019INTRODUCTION
Glycosaminoglycans, structurally heterogeneous polyanions
(PAs), contribute to a wide range of physiological processes
including recognition, adhesion, membrane transport, anti-
bacterial defense, and virus entry (1,2). They interact with
phosphatidylcholine in the presence of Ca2þ (3,4) and are
implicated in ion channel and receptor regulation (e.g.,
(5,6)).Moreover, there are reports indicating a size-dependent
interaction of PAs with ion channels and membranes (7,8).
However, the detailed mechanism of PA influence on ion
channel function is poorly understood. To address this issue,
we studied the effects of two types of differently sized PAs on
the ionic conductance of a mesoscopic ion channel formed by
Staphylococcus aureus a-hemolysin (aHL) in planar lipid
bilayer membranes. The aHL channel is ideally suited for
these studies because its three-dimensional structure, deter-
mined by x-ray crystallography (9), is consistent with many
different experimental techniques (10,11).
We show here that the ability of the PA to block the aHL
channel conductance depended upon the PA properties (i.e.,
structure, size, and type). The interaction appears to occur in
two steps.
First, PA most likely interacts with the aHL channel-
membrane complex via Ca2þ-bridges, resulting in a non-
linear gradient of PA near the complex. Because of the
difference in number of charges and molecular weight, the
PA distribution, close to the channel entrances, depends upon
its size.
Submitted May 19, 2009, and accepted for publication September 4, 2009.
*Correspondence: kras@ufpe.br
Editor: Francisco Bezanilla.
 2009 by the Biophysical Society
0006-3495/09/12/2894/10 $2.00Second, upon occasion, a polyanion, approaching a
channel entrance by diffusion, is forced either into or away
from the pore by the transmembrane electric field.
Linear heparins, which are more flexible (12) than
branched dextran sulfates (DS), were found significantly
more effective than DS of the same molecular weight. The
differences in both the distance between the membrane
surface and the two pore entrances, and the asymmetric
distribution of charges in the two halves of the aHL channel,
determine the strongly pronounced side-dependent differ-
ence in PA effectiveness.
MATERIALS AND METHODS
aHL proteins
Wild-type aHL, which contains no cysteines (13), was purchased from
Calbiochem (San Diego, CA). Point cysteine-substitution aHL mutants
were prepared as previously described (14).
Chemicals
5,50-Dithio-bis-(2-nitrobenzoic acid) (DTNB); dithiothreitol (DTT);
phosphatidylcholine (PC, Type V-E); poly(ethylene glycol) with average
molecular mass of 35,000 g/mol; bovine serum albumin; cholesterol;
heparin-albumin (H-0403; HepAlb, 4.8 mol heparin coupled to 1 mol bovine
serum albumin); heparins (as Na-salt) from porcine intestinal mucosa with
average molecular mass of 18,000 g/mol (most chains in the range
17,000–19,000 Da, H-9399, Hep); 6000 g/mol (H-5284, Hep6000);
3000 g/mol (H-3400, Hep3000); heparin disaccharides III-S with molecular
mass of 563 g/mol (H9392, HepDi); dextran sulfates with average molecular
mass of 500,000 g/mol (D-6001, DS500); 10,000 g/mol (D-6924, DS10);
and 5000 g/mol (D-7037, DS5); and agarose, CaCl2, EDTA, TRIS, and
HCl, were purchased from Sigma (St. Louis, MO). 1,2-Diphytanoyl-sn-glyc-
ero-3-phosphatidylcholine (DiPhyPC) was purchased from Avanti Polar
Lipids (Alabaster, AL). 2-(trimethylammonium) ethyl methanethiosulfonate
Polyanion-Ion Channel Interactions 2895(MTSET) was purchased from Toronto Research Chemicals (North York,
Ontario, Canada). All reagents were used as purchased. Milli-Q plus
18 MU cm deionized water (Millipore, Bedford, MA) was used to prepare
all aqueous buffer solutions. Unless stated otherwise, the solution con-
tained 50 mM CaCl2, 1 mM EDTA, 10 mM TRIS-HCl, at pH 7.5. Such
composition of the solution was chosen to make the effects of PAs more
expressive.
Electrophysiological measurements
Planar lipid bilayer membranes for multi-channel experiments were formed
via the painting technique (15) from a mixture of PC/Chol (1:1, w/w) across
a hole (~0.3mmdiameter) in a 25-mm-thickTeflonpartition in aTeflon cell. In
single channel experiments, the bilayers were formed from DiPhyPC by the
solvent-free method (16). The ionic current was measured at room tempera-
ture (2552C) using anAxopatch200Aamplifier (Axon Instruments, Foster
City, CA) in the voltage-clamp mode. The current was converted to voltage,
filtered by a low-pass eight-pole Butterworth filter, digitized with a sampling
frequency of 0.5 kHz (for multichannel experiments) or 50 kHz (for single
channel recording), stored on a computer and analyzed off-line with the
Whole Cell Electrophysiology Program (WCP V1.7b, J. Dempster, Univer-
sity of Strathclyde, Glasgow, UK) and/or the Electrophysiology software
developed by Dr. M. A. Pustovoit (Petersburg Nuclear Physics Institute,
Gatchina, Russia).
Channels were formed by adding several microliters of the aHL stock
solution (5–50 mg/mL) to one side of the chamber (herein defined as cis).
Each step in current corresponds to the formation of a single, slightly
anion-selective channel (17). The mean value of single-channel insertion
current was 4.8 5 0.3 pA for 50 mM CaCl2 and 40 mV applied potential.
The potential was defined as positive when it was greater at the side of
the protein addition. At pH 7.5, aHL channels are usually in a high conduc-
tance state and rarely switch to low conductance states (18).For multichannel experiments, the contents of the cis side were replaced
by aHL-free solution to keep the number of channels constant. To test the
PA blocking effect, the transmembrane voltage was then increased stepwise
from 0 to 5 100 mV. Control current traces (i.e., with no PA in the bath)
showed no significant channel closure (Fig. 1, C and D). However, in the
presence of PA, 100 mV applied potential caused relatively rapid current
reduction. The decrease in current is described by a single exponential func-
tion (Fig. 1, C and D). The characteristic time constant of the current decay,
t, was used to estimate the action of the PA on the channel. The half-
maximal inhibitory polyanion concentration was defined as IC50.
Liposomes
Liposomes were formed by following a standard procedure (19). Briefly,
2 mg PC dissolved in Folch solution was transferred to a round-bottom glass
flask, and subsequently dried with a nitrogen stream to form a thin film. One
milliliter of the aqueous solution was added to the flask and vigorously
shaken to remove the lipid film from the flask wall. Finally, the mixture
was sonicated (Mini-som; Thornton INPEC Eletro´nica, Vinhedo, Brazil)
to yield an aqueous vesicle suspension (2 mg/mL), which was used the
same day. The size distribution of the phospholipid vesicles (580 5
50 nmmean diameter) was measured using a Zetasizer Nano ZS90 (Malvern
Instruments, Malvern, Worcestershire, UK).
The binding of charged species to the membrane alters the surface and the
z-potentials; therefore, measurement of changes in the liposome z-potential
provides a simple and sensitive method to quantitate the binding of inorganic
and organic compounds to the membrane (4,20). The z-potential was deter-
mined directly from the measured electrophoretic mobility with the Zetasizer
Nano ZS90 (Malvern Instruments). The experiments were performed in the
absence of aHL to determine the degree to which PAs bind to the membrane,
and at a low-ionic-strength aqueous solution (3 mM CaCl2, 1 mM Tris-HCl,
at pH 7.5) to enhance the measurement sensitivity.FIGURE 1 Representations of (A) the aHL channel,
heparin, and DS used in this work, (B) the charge distribu-
tion at the aHL channel, and (C and D) the side-dependent
heparin effect. (A) Cross section through the aHL channel
(Protein Data Bank, 7AHL.pdb) embedded in membrane.
Structure of the dodecameric heparin (Protein Data Bank,
1HPN.pdb; molecular mass of 3453.64 g/mol) and even-
tual structure of the hexadecameric DS (molecular mass
of 5009.56 g/mol) were built with Chem3D (Cambridge-
Soft). (Abbreviations: Hep, heparin; DS, dextran sulfate.)
The atoms are represented using the following color codes:
O (which possesses a negative charge) in red, C in gray,
H in white, N (which possesses a positive charge) in
blue, and S in yellow. (Green triangles) Levels where the
novel Cys and its charged derivatives are located in the
channel structure. Scale bar is 2 nm. (B) The charge distri-
bution was calculated using Coulomb calculation method
(Swiss-PDBViewer, Ver. 3.7) assuming solvent ionic
strength of 0.15 mol dm3, equal to that of the 50 mM
CaCl2 solution mainly used in this study. The isopotential
contouring values, equal to 1.8 kT/e, are shown (red, posi-
tive potentials; blue, negative potentials). (C and D) The
current decays after application of 100 mV steps to multi-
channel bilayers in the presence of Hep6000 at the trans
(C) and cis (D) compartments of the experimental chamber.
(Red lines) Best-fit of a single exponential function.
Control traces (no PA) are shown for comparison. Con-
centrations of Hep6000, voltage protocols, current, and
timescales are given in the figure. Note that the current
inhibition is not total. All other conditions for the experi-
ment are described in Materials and Methods.Biophysical Journal 97(11) 2894–2903
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In this set of experiments, the standard solution also included 1–2 mM DTT.
The sulfhydryl-specific reagents used in this study are small water-soluble
substances with fixed positive or negative charges. They react with cysteine
side chains exposed to the aqueous phase. The reagents were usually applied
to both compartments of the planar bilayer chamber at 0.5 mM (DTNB) or
1.0 mM (MTSET) greater than the concentration of SH-groups of DTT. The
reaction of these reagents with a reduced cysteine side chain converts the
SH group to SS-R, where R is the charged moiety, C6H3NO2COO-
(DTNB) or CH2CH2Nþ(CH3)3 (MTSET).
Artwork
The longitudinal sections of theaHL channel (Protein Data Bank 7AHL.pdb)
were visualized with Swiss-PDBViewer, Ver. 3.7 (21). CS Chem3D Pro
(CambridgeSoft, Cambridge,MA)was used to build the heparin (1HPN.pdb)
and DS structures.
Statistical analysis
Data are reported as the mean 5 SD obtained in 3–7 independent
experiments.
RESULTS AND DISCUSSION
Structural properties of the channel and
polyanions
The aHL channel is ~10-nm long (Fig. 1 A). It is comprised
of both a large cap domain that contains a vestibule with
a maximum diameter of ~4.6 nm and an anti-parallel b-barrel
stem region that spans the membrane (9). Both ends of the
stem region contain a ring of acidic or basic residues sepa-
rated by a 4-nm section of neutral amino acids. The cap
and stem are separated by a constriction with a diameter of
1.2–1.4 nm (9,11,22). Both entrances of the channel are rela-
tively large (diameter ~2.6 nm). The cis pore entrance
extends 4–5 nm from the membrane surface, whereas the
trans entrance is adjacent to the membrane-solution inter-
face. The channel possesses an asymmetric electrostatic
potential distribution (Fig. 1 B) with excess negative charge
at the trans entrance and positive charge at the cis entrance.
Heparin polymers are composed of disaccharide units that
each contain ~3.5 negative charges (23). Nuclear magnetic
resonance suggests that heparin is a relaxed polymer with
a diameter of ~1.3 nm (24), which is less than that of both
pore entrances to the aHL channel (Fig. 1 A). Thus, heparin
should be able to enter the pore.
Dextran sulfates contain up to three sulfate groups per
glucosyl residue. It is composed of ~95% a-D-(1,6) linkages.
The remaining (1,3) linkages cause branching of the polymer.
Estimates for the branch length vary from <3 (25) to >50
glucose units (26). In low-ionic-strength solutions, electro-
static repulsion of the negatively charged sulfate groups will
cause the branches to be extended. The diameter of a given
branch suggests that it could enter the pore. However, the
branched structure of DS (Fig. 1 A) precludes the entry of
the entire molecule in the pore.Biophysical Journal 97(11) 2894–2903Multiple channel experiments: sidedness
We previously demonstrated that heparin (Na-salt; Hoff-
mann-La Roche, Nutley, NJ, with a molecular mass between
10,000 and 80,000 g/mol) blockade of the aHL channel is
side- and voltage-dependent, and requires divalent cations
(27). Specifically, the heparin blocked the pore only when
the sign of the applied potential drives negative ions into
the pore. We further explored these findings and found that
it is true for all PAs reported here.
There was a significant difference in PA effectiveness,
depending on the side to which they were added. Fig. 1, C
and D, shows that PA added to the trans side were more
effective at reducing the channel conductance. The time
courses for the current decay were closely similar for
0.1 mg/mL and 60 mg/mL Hep6000 added to the trans and
cis sides, respectively. Similar sidedness effects were ob-
tained with the other used PAs.
Conceivably, the sidedness effect may be due to an
asymmetry in the fixed charge distribution in the channel
(Fig. 1 B). The more positively charged cis entrance and the
more negatively charged trans side, respectively, should be
more attractive or repulsive, respectively, to PA. Thus, one
would conclude that PA should be more effective in blocking
the aHL channel when added to the cis side. However, the
data suggests otherwise.
There are several possibilities to explain the sidedness.
Because heparin was only effective against the aHL channel
in the presence of divalent cations, we previously suggested
that those cations form bridges between the sulfate groups
of PA and negatively charged side chains in the aHL channel
(27). In this case, the negative electrostatic charges at the trans
entrance may serve as the point of interaction with PA,
making this entrance more sensitive to PA than the positively
charged cis one.Alternatively, the difference in the distance of
the entrances of the aHL channel from the membrane surface
(Fig. 1 A) might be the cause of the sidedness effect (the trans
entrance is much closer to the membrane than is the cis
entrance). The membranes used in our study were made
from the zwitterionic lipid, phosphatidylcholine, and their
surface potential is nearly zero over a large pH range (28).
However, divalent cations (e.g., Ca2þ) interact with the nega-
tively charged phosphate groups of phospholipids and intro-
duce a positive charge at the membrane surface (29). This
action could provide a Ca2þ bridge formation between
phosphate groups of PC and the sulfate groups on the GAG
molecules (30) as well as an increase in concentration of nega-
tively charged PA at membrane-solution interfaces. In turn,
this negatively charged PA concentration-increase should
increase the probability of the channel block by PAs.
Differently sized heparins
To clarify the mechanism of PA influence on aHL channels,
experiments with differently sized heparins and DS were per-
formed. All PAs used demonstrated potent inhibitory
Polyanion-Ion Channel Interactions 2897activities against aHL channel (Fig. 2). The ability of hepa-
rins to block the channel depended on the side to which they
were added, and such ability increased with their concentra-
tion and size (Fig. 2, A, B, and D and Table S1, which is sum-
marizing the results and published as Supporting Material).
The IC50 values were: 38,600 5 6800 and 1350 5
150 ng/mL (Hep3000); 61005 400 and 19.15 6.2 ng/mL
(Hep6000); 330 5 50 and 4.6 5 0.3 ng/mL (Hep); and
52 5 6 and 0.44 5 0.07 ng/mL (HepAlb), added to the
cis and the trans sides, respectively. The smallest heparin,
HepDi, had virtually no effect on the aHL channel current,
even at 2 mg/mL. Thus, despite their lesser diffusion coeffi-
cients, the larger heparins are more effective and caused the
channel current to decay more rapidly. The heparins used in
this study ranked as follows in order of decreasing effective-
ness: HepAlb > Hep > Hep6000 > Hep3000 >> HepDi.
The dependence of the IC50 on heparin molecular weight
was linear in log-log plot (Fig. 2 C). A 10-fold increase in the
polyanion size increased the polyanion’s effectiveness
>1000-fold.Extrapolationofa linear regression,obtainedat the
cis and trans polyanion additions to the experimental value of
IC50 of the HepAlb complex (symbolized as a star in Fig. 2C),
suggests that HepAlb acts as a polyanion with an effective
molecular mass of 31,000 5 2000 g/mol. This is approxi-
mately twofold greater than the average molecular mass of
a single Hep bound to Alb, but less than the sum all of 4–5
Hep molecules linked to Alb (i.e., 72,000–90,000 g/mol,
assuming an average Hep molecular mass of 18,000 g/mol).
The high effectiveness of HepAlb (IC50 ¼ 525 6 ng/ml;
added to cis) warranted further study. To better understand
its interaction with the channel, additional experiments
were performed in which Hep was not chemically coupled
to Alb but only mixed with it at the same molar ratio. Theresults demonstrate that the Hep-Alb mixture is approxi-
mately eight times less effective in blocking the aHL
channel (IC50 ¼ 2500 5 500 ng/mL) than Hep itself
(IC50 ¼ 330 5 50 ng/mL), which in turn, is approximately
six times less potent than HepAlb. Thus, Alb when mixed
with Hep even inhibits the latter’s action. This effect of
Alb might be due to its ability to bind heparin electrostati-
cally (31) in a proportion corresponding to 3–4 Alb bound
per Hep molecule, based on a molecular mass of 18,000
g/mol. Alb could bind calcium ions, most likely, via ionized
carboxyl groups (32), and then absorb at lipid bilayers,
possibly via hydrophobic interactions (33). These hydro-
phobic interactions may result in covering of the membrane
surface, thereby preventing its interaction with Hep—which,
in turn, leads to decreased PA concentration near the
membrane surface and decreased effectiveness. Thus, Hep
chemically coupled to Alb does not act as a simple mixture
but as a one-piece heparin with a high molecular weight.
The size of the Alb (5  8  9 nm, 1BM0.pdb) is consider-
ably larger than the size of the aHL channel entrances.
Hence, HepAlb need not be transported completely through
the pore to elicit its effect.
Differently sized dextran sulfates
Other PAs (e.g., DS) also cause the aHL channel current to
decrease (Fig. 2 D). The effectiveness of DS species
increases with their size: the IC50 values were 220.0 5
30.0 mg/mL (DS5), 7.2 5 1.5 mg/mL (DS10), and 1.7 5
0.3 mg/mL (DS500). DS have a larger negative charge
density than the heparins, but they were significantly less
effective against the aHL channel. The difference between
PAs topologies most likely accounts for this result.FIGURE 2 Influence of polyanions on aHL channel
current reduction. aHL channel blockage as a function of
heparin’s concentration in the (A) cis or (B) trans compart-
ment of the chamber. (Solid line) Best-fit of a one-site-
binding equation. (Symbols: B, HepAlb; -, Hep; 7,
Hep6000; and:, Hep3000.) (C) The interrelation between
molecular weight and IC50 of heparin. (Solid line) First-
order regression through the points. (Dashed lines) Extrap-
olations of the dependences to experimentally established
values of IC50 to HepAlb (x). (Arrow) Apparent molecular
weight of heparin in HepAlb. The value r is a correlation
coefficient. (D) The influence of DS (presented in the cis
compartment of the chamber) on aHL channel blockage.
Effect of the Hep is shown for comparison. (Solid line)
Best-fit of a one-site-binding equation. (Symbols: -,
Hep; 6, DS500; C, DS10; and ,, DS5.) Data are re-
ported as means5 SD obtained in 5–7 independent exper-
iments like those shown in Fig. 1, C and D.Biophysical Journal 97(11) 2894–2903
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are linear. In addition, heparins are presumably highly flex-
ible because of the iduronate residues in their structure,
unlike other pyranose rings, can adopt a range of different
ring conformations such as chair, 1C4 or
4C1, or skew-boat,
2S0, depending on the nature of adjacent residues and the
microenvironment (34).
Single channel experiments
As it was shown above, all PAs decreased the current
through a membrane containing multiple channels. To better
understand this effect, we performed experiments with single
channels. As an example, Hep3000 reduces the pore conduc-
tance to one much lower conductance state (Fig. 3, A and C).
As expected from the multichannel recordings, the time
constant for PA to block the single channel conductance is
inversely proportional to the applied potential (Fig. 3 B)
and is dependent on PA concentration (i.e., the greater the
concentration, the more likely the channel is in the blocked
state). The amplitude of the current reduction caused by
Hep3000 is side-dependent (Fig. 3 C). Specifically, the
conductance reduction is greater for heparin added to the
trans side. This result is consistent with the channel struc-
ture: the trans region of the pore is narrower than the cis
region. The other PAs used act similarly (data not shown).
The PA-induced aHL channel conductance block resem-
bles the channel gating observed at low pH and higher
applied potential (18). However, there is a significant differ-
ence. The gating caused by pH and high voltages exhibits
several low conductance states. In contrast, the blocked
conductance distribution caused by heparin is unimodalBiophysical Journal 97(11) 2894–2903(Fig. 3 C). The results above are not consistent with a struc-
tural rearrangement of the channel structure caused by the
transmembrane potential and facilitated by PA. On the
contrary, the results suggest that heparins reduce the channel
conductance by blocking the ion conduction pathway in
the pore.
The data shown in Fig. 3 A demonstrate that heparin mole-
cules interact with the pore at different timescales. Specifi-
cally, there are transient and long-lived current blockades.
We performed a spectral analysis of the current noise (35)
to estimate the dynamics of the more rapid polyanion-
channel interactions. The source of useful signals in this
case would be the random fluctuations in the number of
heparin molecules in immediate proximity to the channel
entrance, i.e., the access resistance (36) and/or in the channel
pore (35). The background and PA signals were the current
of the fully open aHL channel in the absence and presence of
heparins (i.e., excluding the large conductance transients),
respectively (e.g., see the circle in Fig. 3 A). Heparin
increases the aHL current noise (Fig. S1 in the Supporting
Material) and the increase is side- and voltage-dependent.
The effect, albeit not great, suggests that heparin molecules
passed several times in the immediate proximity of the
channel entrance before entering and plugging the pore.
Cysteine-substitution mutants
Our objective was to determine the significance of electro-
static force in a polyanion’s effective ability to block the
aHL channel. Genetically engineered versions of aHL
with novel charges located at the channel entrances were
used for this purpose. Because the primary sequence ofFIGURE 3 Heparin effects at the single channel level.
(A) Single aHL channel. The representative current trace
was recorded at 140 mV. Hep3000 (390 mg/mL) was
placed at the trans side. Recording was performed at
0.02-ms resolution. (Vertical arrow) Channel insertion.
(Rectangle) A single short-blockage-event shown in higher
time-resolution (inset). (Circle) Example of the trace used
in current noise analysis. The respective all-point histo-
grams are shown at the right, where Z denotes the current
through unmodified lipid bilayer, and O and B correspond
to the open and blocked channel levels, respectively. (B)
Probability to find the channel in fully open state in the
presence of Hep3000 (130 mM) at the cis or at the trans
compartment. (Solid lines) Best-fit of a first-order exponen-
tial function. An e-fold change in the probability of being
open was observed for change in every 24 mV. (C)
Conductance histograms of the residual conductance of
the channel under influence of Hep3000. The histograms
were comprised from the observation of the approximately
100 blockage events shown in panel A. Bin width was 4 pS.
(Solid line) Best-fit of a single normal distribution to the
most probable conductance values for Hep3000 acting
from the trans and the cis entrances of the aHL channel.
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mutants (I7C and T129C, with cysteine located close to the
cis and trans pore entrances, respectively; green triangles
in Fig. 1 A). We subsequently chemically modified these
cysteine side chains with small water-soluble sulfhydryl-
specific reagents to add either a full positive or a negative
charge at each cysteine side chain. Because the aHL channel
is a heptamer, these agents added up to seven positive or
negative charges in the pore lumen.
Theoretical considerations suppose that the conversion of
the weak negative charge on cysteine to a strong negative or
positive value, causes significant changes in the electrostatic
potential distribution that is spread evenly at the opposite
channel entrance (Fig. S2 in the Supporting Material). Such
changes in the potential might affect the polyanion concen-
tration near both channel entrances. As a result, the change
in the effectiveness of PA could be expected not only at
the side of the charge addition but at the opposite side as
well.
Experiments showed that when full fixed charges are
added to the channel entrances, the effect of PA on the
channel conductance is markedly altered (Fig. 4). Moreover,
the effect of added charges on the trans side is felt on the
other (cis) side of the channel, and vice versa. For example,
adding a single novel negative charge per monomer at posi-
tion 7 significantly increased the time constant of heparin-
induced channel blockade Hep6000 at the cis side and
100 mV applied potential (Fig. 4 A). A small, but visible
increase in the time constant was found with Hep6000 added
to the trans side and þ100 mV applied potential (Fig. 4 B).
A novel positive charge at the position causes the opposite
effect, i.e., an increase in heparin’s effectiveness (a decrease
in the time constant) when it was added to the either side(Fig. 4, A and B). Qualitatively similar, but stronger effects,
were observed for charges added at the trans entrance, where
the added charges greatly affect the heparin effectiveness
from the trans side and weakly affect them from the cis
(Fig. 4, C and D). Thus, in agreement with the estimated
electrostatic potential distribution (Fig. S2 in the Supporting
Material), the novel charges alter the current blocking effect
of PA not only at the modified aHL channel entrance but
also at the opposite entrance (Fig. 4). The results are not
consistent with Ca2þ bridge formation between the nega-
tively charged residues of the pore lumen and sulfate groups
of PA. Instead, they suggest the electrostatic potential, gener-
ated by these charged residues, modifies the effective
concentration of heparin near the pore entrances and that
the last step of the polyanion-channel interaction (blocking)
is electrostatic in nature. Qualitatively similar results were
observed with other PA used (data not shown).
Liposomes
PA appears to enter and occlude the aHL channel. However,
the question of why the larger molecular weight PA is so
effective at reducing the channel conductance (Fig. 2)
remains. It was conceivable that PA accumulates in the
channel access resistance region in a voltage-dependent
manner (37). Because of the difference in diffusion coeffi-
cient and electrophoteric mobility, this Ansatz predicts that
the smaller PAs accumulate more rapidly close to the pore
entrance than do the larger ones. Thus, one could expect
the smaller PA to be more effective in blocking the aHL
channel, which is not consistent with the data.
To explain these results, we determined the interaction
between the PAs and the membrane surface. Phospholipids,FIGURE 4 Influence of the strong positive or negative
charge at the lumen of the channel close to the cis (A
and B; I7C) or the trans (C and D; T129C) aHL channel
entrance on the heparin effects. Multichannel lipid bilayers
were used. Maximal value of the current, seen soon after
potential shift from zero mV, was taken as 100 arbitrary
units. Hep6000 was used at concentration of ~4 mg/mL at
the cis compartment (A and C) when voltage was switched
from 0 to 100 mV. In experiments with 0–100 mV
voltage switch, Hep6000 was used at a concentration of
~0.4 mg/mL at the trans compartment (B and D). The traces
labeled DTT are the Cys mutants kept in a reduced form.
The reagents used for derivatization of cysteine (DTNB,
MTSET) are given in the figure.Biophysical Journal 97(11) 2894–2903
2900 Teixeira et al.including PC, interact with PA (e.g., (4,8)). Binding PA with
phospholipids does not occur in the absence of divalent
cations. These cations form bridges between negatively
charged phosphate groups of the phospholipids and the
sulfate groups on PA (8). Phospholipids and PA interact
with divalent cations individually (38,39). This apparently
does not impair the Ca2þ bridge formation between phos-
pholipids and PA, most likely because both are in dynamic
equilibrium with free ions in the bulk. Moreover, the data
suggest that PA, and heparin, in particular, continue to
possess a negative net charge even in 100 mM Ca2þ solution
(27). Because heparins also require the presence of divalent
cations in the bulk to affect the channel (27), we considered
the possibility that heparins bind to the membrane, in agree-
ment with the calcium-bridge mechanism suggested in the
literature (8,30,41).
Polyanion-binding to liposomes causes a negative
z-potential (4). In particular, the effect of DS is increased
with concentration and molecular weight (8). To verify
whether the same is true for heparins and to quantify the
binding of these PAs to the membrane, we measured the
z-potential of PC liposomes in the absence and presence of
differently sized heparins. This effort might help us in under-
standing the mechanism of PA action, and, in particular, its
sidedness effect at the aHL channel.
We found that heparins decreased the PC liposome
z-potential from slightly positive value (in the absence of
PA) up to ~24 mV (Fig. 5). The larger heparins were
more active. The dependence of liposome z-potential
(Fig. 5) on heparin concentration resembles that for heparin-
induced aHL channel current blockade (Fig. 2). There is
a strong correlation between the effectiveness of heparins
(presented as the IC50) in these two systems (Fig. 5, inset).
These results suggest that the binding of PA with the
membrane might account for the strong dependence of the
FIGURE 5 z-Potential of liposomes in the presence of growing concentra-
tions of heparins and the correlation between equi-effective concentration of
heparins against liposomes and aHL channels (inset). (Symbols:B, Hep-
Alb;-, Hep;,, Hep6000; and6, Hep3000.) The value r is the correlation
coefficient.Biophysical Journal 97(11) 2894–2903channel blockade on PA molecular weight. It appears that at
the first step of PA-ion channel interaction, PA binds to
membrane via Ca2þ-bridges, resulting in higher local concen-
trations on and near the membrane and thus around the aHL
pore entrance area. This proximity to the pore entrance
increases the probability that, at the right polarity, the pore-
ion flux would be inhibited by the polyanion.
The results account for the side-differential effectiveness
of PA. The steady-state polyanion concentration decreases
nonlinearly (41) with distance from the surface, down to
their bulk value. As a result, at the same bulk concentration,
the effective steady-state polyanion concentration should be
much higher at the trans (nearly to the membrane surface,
but negatively charged) than cis (far from the membrane
surface, but positively charged) entrance of the channel.
The latter clarifies how the difference in the distance between
the membrane surface and the entrances of the channel may
determine the sidedness in PA effectiveness. Unbound poly-
mer can occasionally approach the channel entrance by
diffusion and then (at the second step of PA/ion channel
interaction) enter the pore in a voltage-dependent manner
and block it.
The lipid bilayer binds PA in a divalent cation-mediated
manner. This leads to two consequences:
First, the binding increases the PA concentration close to
the membrane surface in a molecular-weight-dependent
manner—which, in turn, increases the probability of its
blocking the aHL channel, as demonstrated in this study.
Second, the binding might alter the packing and the phase
transition of lipid chains of membrane phospholipids (40),
which can modify the aHL-membrane interaction (42) and,
most likely, the channel transition between voltage-depen-
dent states of different conductances. This then raises a ques-
tion about the role of the physical state of membranes in the
mechanism of PA action against ion channels—including
those formed by aHL.
Theoretical model
Assuming that the distribution of PA adjacent to the
membrane-solution interface follows the Boltzmann law
(41), the effective polyanion concentration at the channel
entrance, Ci, is
Ci ¼ Coezji ; (1)
where Co is the polyanion concentration in the bulk, z is its
valence, and ji is the dimensionless potential at a channel
entrance (jCis or jTrans).
We assume that PAs have the same concentration at the
channel entrance, C0i ¼ C00i, to cause the same current block-
ing effect. In that case, the ratio of bulk concentrations of two
PA can be estimated as
C
0
o
C00o
¼ eðz
0 z00Þji (2)
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ln
C
0
o
C00o
¼ z0  z00ji; (3)
where C0o and z0 and C00o and z00 are the bulk concen-
tration and valence of two different PAs in the contact
with the same (cis or trans) channel entrance in separate
experiments.
The fit of Eqs. 2 and 3 to the dependence of the relative
effectiveness of different heparins in the channel-block on
their charge difference is shown in Fig. 6. The good agree-
ment supports our assumption that the PA concentration
close to surface of the membrane-aHL channel-complex
obeys the Boltzmann law and that, at equal bulk concentra-
tion, the larger PAs have a greater concentration near the
channel entrances. The numerical value of the potential
responsible for the difference in effectiveness of differently
sized PAs could be obtained by extrapolating the experi-
mental dependencies shown in Fig. 6 (inset) to z0 z00 ¼ 1.
For the experiments with heparins added to the cis side or
the trans side, values of ji were ~1.55 and ~4.45. The result
indicates that the effective potential, which is responsible for
the difference in PA concentration at the aHL channel
entrances, is approximately three times smaller at the cis
than at the trans side.
To clarify the participation of the membrane in determina-
tion of this potential, we used the Debye-Hu¨ckel approxima-
tion, ji ¼ joekc, where k1 is the Debye screening length,
and c is the distance between potential at the membrane
surface, jo, and potential at the some distance from it, ji.
Comparing the Debye-Hu¨ckel equations for the cis and
trans entrances of the channel, we estimate the ratio of
FIGURE 6 Relative effectiveness of heparins at the cis and the trans
applications against their charge difference is presented in linear and
semi-logarithmic (inset) plot. To build the plots, values of IC50 were taken
in nM. The ratio was defined as IC
Hep3000
50 =IC
Hepi
50 . The number of charges
per a heparin molecule, z, was taken equal to the number of sulfate groups.
The effective charge difference was defined as ZHep3000–ZHepi. The correla-
tion coefficient between experimental data and theory is >0.99.potentials at the cis and trans aHL channel entrances to be
jcis=jtrans ¼ ekðDcÞ, where Dc represents the apparent
difference in distance between the cis and trans channel
entrances from the membrane surface. Substituting Dc for
4 nm (based on the available data about aHL channel posi-
tion in lipid bilayer), and taking k1¼ 0.8 nm (ionic strength
~0.15), we found jcis=jtrans of 0.007, which is ~50 times less
than the experimental value. The result indicates that, in the
absence of electrostatic potential generated by the protein
part of the aHL channel, the sidedness effect of PA should
be remarkably more pronounced. Thus, potential of the
membrane surface alone explains the experimental side-
dependence of polyanion action qualitatively. The protein
channel attenuates the potential generated by lipid
membrane. The resulting effective potential (responsible
for the polyanion concentration at the entrances) is the result
of both constituents of the aHL channel-membrane complex.
The influence of the charged regions of the aHL channel is
electrostatic in nature. The transmembrane potential does
not determine PA concentration close to the channel
entrances (see Supporting Material for a detailed discussion).
The transmembrane potential acts at the second step, where
a polyanion, occasionally approaching a channel entrance by
diffusion, is forced either into or away from the pore by the
transmembrane electric field. Ca2þ-bridges mediate the inter-
action of PA with lipid membranes only.
CONCLUSION
Here, we demonstrate that the ability of heparins and DS to
block aHL channels correlates with their binding to a phos-
pholipid membrane and significantly increases with polyan-
ion size. The effectiveness of PA reported here depends
strongly on the side to which they were added and on the
sign of transmembrane voltage applied. In summary, the
results obtained with wild-type and genetically engineered
channels together with a simplified mathematical analysis of
the data suggested particularmechanisms bywhichPAs affect
the aHL channel, and perhaps other mesoscopic channels.
The interaction between the channel and PA requires two
steps. First, PAs bind reversibly to the membrane surface via
Ca2þ-bridges. The distribution of PAs close to the surface is
determined by two factors: an attraction to membrane (which
retains PA at the surface via Ca2þ-bridges) and Brownian
diffusion (which tends to equalize their surface and the
bulk concentrations). At equilibrium, the polyanion concen-
tration distribution is greatest close to the surface and
decreases with distance in an exponential manner (41). At
the same bulk concentration, the larger PA is at the larger
concentration in proximity to the surface. Because the two
entrances of the aHL channel are at different distances
from the membrane surface, the effective concentration of
PA at the cis entrance is much smaller than at the trans.
This qualitatively explains the difference in their effective-
ness from the cis and the trans side.Biophysical Journal 97(11) 2894–2903
2902 Teixeira et al.PAs have a negative net charge even in 100 mM solution
of CaCl2 (27). The visible interaction of PAs with aHL chan-
nels occurs at the second step when a polyanion, which occa-
sionally diffuses to the access zone on the front of the
channel entrance, will fall under the influence of the trans-
membrane electric field, preventing or facilitating its
entrance into the channel lumen to plug it. It appears that,
at this step, the interaction of PA with the channel is not
mediated by Ca2þ-bridges, and that long-range electrostatic
interactions are important. The conclusion is consistent
with the earlier observed (27) decrease in heparin effective-
ness under the increase in ionic strength of the bulk solution
and the theoretical estimations of blocking of an ion channel
by a highly charged drug (43).
Findings provide a noncontradictory molecular explana-
tion for polyanion/protein-ion channel interactions that
combines all data known to date including the necessity of
divalent cations, voltage-, side-, and size-dependencies of
PA effect on the aHL channel. The results shown here might
be of interest for pharmacology and biomedicine, where
heparins and other PAs are widely used, and are of impor-
tance for understanding the ubiquitous role of PA in cellular
activity. We expect that the results obtained here will be
applicable to other mesoscopic (proteinaceous and synthetic)
water-filled nanopores, and should be helpful in research to
design drugs that might block mesoscopic pores formed by
channel-forming toxins (e.g., (44)).
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